title: Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases.
abstract: Receptor tyrosine kinases (RTKs) activate pathways mediated by serine-threonine kinases, such as the PI3K (phosphatidylinositol 3-kinase)-Akt pathway, the Ras-MAPK (mitogen-activated protein kinase)-RSK (ribosomal S6 kinase) pathway, and the mTOR (mammalian target of rapamycin)-p70 S6 pathway, that control important aspects of cell growth, proliferation, and survival. The Akt, RSK, and p70 S6 family of protein kinases transmits signals by phosphorylating substrates on an RxRxxS/T motif (R, arginine; S, serine; T, threonine; and x, any amino acid). We developed a large-scale proteomic approach to identify more than 300 substrates of this kinase family in cancer cell lines driven by the c-Met, epidermal growth factor receptor (EGFR), or platelet-derived growth factor receptor alpha (PDGFRalpha) RTKs. We identified a subset of proteins with RxRxxS/T sites for which phosphorylation was decreased by RTK inhibitors (RTKIs), as well as by inhibitors of the PI3K, mTOR, and MAPK pathways, and we determined the effects of small interfering RNA directed against these substrates on cell viability. Phosphorylation of the protein chaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) at serine-305 was essential for PDGFRalpha stabilization and cell survival in PDGFRalpha-dependent cancer cells. Our approach provides a new view of RTK and Akt-RSK-S6 kinase signaling, revealing previously unidentified Akt-RSK-S6 kinase substrates that merit further consideration as targets for combination therapy with RTKIs.
authors.affiliation: Cell Signaling Technology Inc., Danvers, MA 01923, USA.
authors.forename: Albrecht
authors.initials: A
authors.lastname: Moritz
authors.forename: Yu
authors.initials: Y
authors.lastname: Li
authors.forename: Ailan
authors.initials: A
authors.lastname: Guo
authors.forename: Judit
authors.initials: J
authors.lastname: Villén
authors.forename: Yi
authors.initials: Y
authors.lastname: Wang
authors.forename: Joan
authors.initials: J
authors.lastname: MacNeill
authors.forename: Jon
authors.initials: J
authors.lastname: Kornhauser
authors.forename: Kam
authors.initials: K
authors.lastname: Sprott
authors.forename: Jing
authors.initials: J
authors.lastname: Zhou
authors.forename: Anthony
authors.initials: A
authors.lastname: Possemato
authors.forename: Jian Min
authors.initials: JM
authors.lastname: Ren
authors.forename: Peter
authors.initials: P
authors.lastname: Hornbeck
authors.forename: Lewis C
authors.initials: LC
authors.lastname: Cantley
authors.forename: Steven P
authors.initials: SP
authors.lastname: Gygi
authors.forename: John
authors.initials: J
authors.lastname: Rush
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Comb
mesh_terms: D020816:Amino Acid Motifs; D002352:Carrier Proteins / Q000737:chemistry / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D018832:Molecular Chaperones; D010455:Peptides / Q000737:chemistry* / Q000378:metabolism; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000737:chemistry* / Q000378:metabolism; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000737:chemistry* / Q000378:metabolism; D038762:Ribosomal Protein S6 Kinases, 70-kDa / Q000737:chemistry* / Q000378:metabolism; D013379:Substrate Specificity; D058570:TOR Serine-Threonine Kinases / Q000737:chemistry* / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; D018832:Molecular Chaperones; D010455:Peptides; C114575:SGTA protein, human; C546842:MTOR protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha; D051057:Proto-Oncogene Proteins c-akt; D038762:Ribosomal Protein S6 Kinases, 70-kDa; D058570:TOR Serine-Threonine Kinases